Two studies have shown that chronic administration of 7,8-dihydroxyflavone improves depression-like behaviors in rats by acting as an agonist on the TrkB receptor, which subsequently increases hippocampal expression of BDNF (Zhang et al., 2014; Zhang et al., 2016). The gene discussed is BDNF; the disease is depressive disorder.